1- Suárez,
J.
C.,
Zunino,
S.,
Viano,
J.
C.et al.Gliomas cerebrales de bajo grado en el adulto,
Rev Argent Neuroc.
2008;22:15-20.
2- Grier JT,
Batchelor T.
Low-grade gliomas in adults.
Oncologist.
2006;11(6):681–693.
3- Pouratian N,
Schiff D.
Management of low-grade glioma.
Curr Neurol Neurosci Rep.
2010;10(3):224–31.
4- Moreno-jiménez S,
Alonso-vanegas M,
Aviléz AB,
et al.
Oligodendrogliomas en el Instituto Nacional de Neurología y Neurocirugía: comportamiento biológico en una población definida.
2005;10(3):140–145.
5- Louis DN,
Ohgaki H,
Wiestler OD,
et al.
The 2007 WHO classification of tumours of the central nervous system.
Acta Neuropathol.
2007;114(2):97–109.
6- Kao H-W,
Chiang S-W,
Chung H-W,
Tsai FY,
Chen C-Y.
Advanced MR imaging of gliomas: an update.
Biomed Res Int.
2013;2013:970586.
7- Horská A,
Barker PB.
Imaging of brain tumors: MR spectroscopy and metabolic imaging.
Neuroimaging Clin N Am.
2010;20:293–310.
8- Brandão LA,
Castillo M.
Adult Brain Tumors: Clinical Applications of Magnetic Resonance Spectroscopy.
Neuroimaging Clin N Am.
2013;23:527–555.
9- Li C,
Ai B,
Li Y,
Qi H,
Wu L.
Susceptibility-weighted imaging in grading brain astrocytomas.
Eur J Radiol.
2010;75(1):e81–5.
doi:10.1016/j.ejrad.2009.08.003.
10- Cha S,
Tihan T,
Crawford F,
et al.
Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging.
AJNR Am J Neuroradiol.
2005;26(2):266–273.
11- Majós C,
Aguilera C,
Alonso J,
et al.
Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses.
AJNR Am J Neuroradiol.
2009;30(3):544–551.
12- Arita YN.
The 71st Annual Meeting Special Topics — Part III : Treatment Strategy of Low Grade Glioma Current Knowledge and Treatment Strategies for Grade II Gliomas.
2013.
13- van den Bent MJ,
Snijders TJ,
Bromberg JEC.
Current treatment of low grade gliomas.
Memo.
2012;5(3):223–227.
14- Bizzi A.
Presurgical Mapping of Verbal Language in Brain Tumors with Functional MR Imaging and MR Tractography.
Neuroimaging Clin N Am.
2009;19:573–596.
15- Guillevin R,
Menuel C,
Taillibert S,
et al.
Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.
Br J Cancer.
2011;104(12):1854–1861.
16- Jenkinson MD,
du Plessis DG,
Smith TS,
Joyce K a,
Warnke PC,
Walker C.
Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features.
Brain.
2006;129(Pt 7):1884–1891.
doi:10.1093/brain/awl108.
17- Khayal IS,
Vandenberg SR,
Smith KJ,
et al.
N E U RO - O N CO LO GY MRI apparent diffusion coefficient reflects.
2011;13(11):1192–1201.
18- Caseiras GB,
Chheang S,
Babb J,
et al.
Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting.
Eur J Radiol.
2010;73(2):215–220.
19- Hattingen E,
Raab P,
Franz K,
et al.
Prognostic value of choline and creatine in WHO grade II gliomas.
Neuroradiology.
2008;50(9):759–767.
20- Brasil Caseiras G,
Ciccarelli O,
Altmann DR,
et al.
Tumor Growth Predicts Patient Outcome Better than Admission.
Radiology.
2009;253(2):505–512.
21- Van den Bent MJ,
Wefel JS,
Schiff D,
et al.
Response assessment in neuro-oncology (a report of the RANO group): Assessment of outcome in trials of diffuse low-grade gliomas.
Lancet Oncol.
2011;12(6):583–593.
22- Guillevin R,
Menuel C,
Taillibert S,
et al.
Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.
Br J Cancer.
2011;104(12):1854–1861.
23- Romano a,
Rossi Espagnet MC,
Calabria LF,
et al.
Clinical applications of dynamic susceptibility contrast perfusion-weighted MR imaging in brain tumours.
Radiol Med.
2012;117(3):445–60.
24- Law M,
Yang S,
Wang H,
et al.
Glioma grading: sensitivity,
specificity,
and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
AJNR AmJNeuroradiol.
2003;24(0195-6108 (Print)):1989–1998.
25- Yoon JH,
Kim J-H,
Kang WJ,
et al.
Grading of Cerebral Glioma with Multiparametric MR Imaging and (18)F-FDG-PET: Concordance and Accuracy.
Eur Radiol.
2013;24(2):380–389.
26- Goebell E,
Paustenbach S,
Vaeterlein,
et al.
Low-Grade And Anaplastic Gliomas: Differences in Architecture Evaluated with Diffusion-Tensor Imagin.
Radiology.
2006;239(1):217–222.
27- Ius T,
Isola M,
Budai R,
et al.
Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival.
A single-institution experience in 190 patients.
J Neurosurg.
2012;117(December):1–14.
28- Skrap M,
Mondani M,
Tomasino B,
et al.
Surgery of insular nonenhancing gliomas: volumetric analysis of tumoral resection,
clinical outcome,
and survival in a consecutive series of 66 cases.
Neurosurgery.
2012;70(5):1081–93; discussion 1093–4.
29- Bayrakli F,
Dinçer A,
Sav A,
Vardareli E,
Peker S.
Late brain stem radionecrosis seventeen years after fractionated radiotherapy.
Turk Neurosurg.
2009;19:182–185.